Provided by Tiger Fintech (Singapore) Pte. Ltd.

Krystal Biotech Inc.

132.09
+2.071.59%
Post-market: 132.090.00000.00%19:27 EDT
Volume:354.14K
Turnover:46.39M
Market Cap:3.82B
PE:31.79
High:132.35
Open:130.86
Low:127.99
Close:130.02
Loading ...

AZN Gets EU Nod for Expanded Use of Two Separate Cancer Drugs

Zacks
·
07 Apr

AMGN's Uplizna Gets FDA Nod for 2nd Rare Autoimmune Disease Indication

Zacks
·
05 Apr

SNY's Rilzabrutinib Gets FDA's Orphan Drug Tag for Two Rare Diseases

Zacks
·
03 Apr

William Blair Keeps Their Buy Rating on Krystal Biotech (KRYS)

TIPRANKS
·
03 Apr

Alkermes Begins Idiopathic Hypersomnia Study on ALKS 2680

Zacks
·
02 Apr

VRTX Provides Mixed Updates for Type 1 Diabetes Pipeline Candidates

Zacks
·
01 Apr

Mirum Pharmaceuticals (MIRM) Down 1.9% Since Last Earnings Report: Can It Rebound?

Zacks
·
28 Mar

BEAM's IND for BEAM-302 in Genetic Disorder Study Gets FDA Clearance

Zacks
·
28 Mar

Sanofi's Chlamydia Vaccine Candidate Gets FDA's Fast Track Tag

Zacks
·
26 Mar

US High Growth Tech Stocks With Promising Potential

Simply Wall St.
·
26 Mar

3 High Growth Companies Insiders Are Betting On

Simply Wall St.
·
22 Mar

Krystal Biotech (KRYS) Up 3.3% Since Last Earnings Report: Can It Continue?

Zacks
·
21 Mar

Krystal Biotech Rises 15.8% in a Month: Should You Buy Now or Wait?

Zacks
·
08 Mar

Top Research Reports for Walmart, HSBC & Adobe

Zacks
·
08 Mar

Jefferies Initiates Krystal Biotech at Buy With $245 Price Target

MT Newswires Live
·
05 Mar

Krystal Biotech Initiated at Buy by Jefferies

Dow Jones
·
05 Mar

Krystal Biotech initiated with a Buy at Jefferies

TIPRANKS
·
05 Mar

Krystal Biotech’s Growth Potential: Strong Vyjuvek Launch and Promising Pipeline

TIPRANKS
·
05 Mar

KRYS Gets Positive CHMP Opinion for EU Approval of Skin Disease Drug

Zacks
·
03 Mar

Analysts Offer Insights on Healthcare Companies: Krystal Biotech (KRYS) and BioCryst (BCRX)

TIPRANKS
·
03 Mar